Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624046 · ClinicalTrials.gov registry record · NA
Circadian Mechanisms, Glucose, and CV Risks in T1D
A NA study of Type 1 Diabetes (T1D), sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06624046: Recruiting NA study of Type 1 Diabetes (T1D), sponsored by University of Illinois at Chicago.
NCT06624046 is a NA study of Type 1 Diabetes (T1D) that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 100 participants, below the 175-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06624046, a NA study of Type 1 Diabetes (T1D), is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.
Primary Outcome
Continuous glucose monitor (CGM)
Conditions Studied
Interventions
- BEHAVIORAL Sleep stability intervention
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
What NCT06624046 shows while recruiting
NCT06624046 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 175-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Sleep stability intervention is the first listed.
NCT06624046 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06624046 about?
NCT06624046 is a clinical study titled "Circadian Mechanisms, Glucose, and CV Risks in T1D". People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving...
What is the current status of trial NCT06624046?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-03-13. Estimated completion is 2029-08-31.
What conditions does trial NCT06624046 study?
This clinical trial studies the following conditions: Type 1 Diabetes (T1D).
What interventions are being tested in trial NCT06624046?
The interventions under investigation include: Sleep stability intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06624046?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06624046 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes (T1D)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06624046's enrollment target sits among peer trials
100 5th of 17 higher than 13 of 17 other Type 1 Diabetes (T1D) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes (T1D) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
RECRUITING · NA
-
Automated Insulin for Management of Intrapartum Glycemia
RECRUITING · NA
-
Digital Mindfulness for Young Adults With Type 1 Diabetes
RECRUITING · NA
-
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI